Nuva
-
Financial
NuVasive (NUVA) Is in Oversold Territory: What’s Next?
NuVasive, Inc. NUVA has been on a bit of a cold streak lately, but there might be light at the end…
Read More » -
Spine
NuVasive wins a round in patent battle with Medtronic
FEBRUARY 19, 2016 BY BRAD PERRIELLO NuVasive Inc. (NSDQ:NUVA) this week won a round in its long-standing intellectual property feud with Medtronic (NYSE:MDT) when a…
Read More » -
Spine
NuVasive to Acquire Ellipse Technologies
Reflects NuVasive’s Focus on Transformative Spine Solutions, Reinforces Leadership Position With the Addition of Fast-Growing Complex Deformity Franchise; Expected to…
Read More » -
Recon
NUVASIVE APPOINTS GREGORY T. LUCIER CHIEF EXECUTIVE OFFICER
SAN DIEGO, CA – MAY 26, 2015 – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a leading medical device company…
Read More » -
Spine
NuVasive(R) Launches Integrated Global Alignment (iGA(TM)) Platform at AANS 2015
NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive or the “Company”), a leading medical device company focused on transforming spine surgery with minimally…
Read More » -
Financial
NuVasive® Reaches Agreement in Principle to Settle OIG Matter
SAN DIEGO, CA–(Marketwired – April 29, 2015) – NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company…
Read More » -
Financial
Wall Street Places $54.5 Price Target on NuVasive, Inc. (NASDAQ:NUVA)
By Seth Talluto In looking at the consensus numbers, the sell-side analysts covering the stock have a mean target price…
Read More » -
Financial
NuVasive CEO Resigns After Probe Finds Policy Violations
By TESS STYNES April 1, 2015 9:40 a.m. ET NuVasive Inc. said Chairman and Chief Executive Alex Lukianov resigned after…
Read More » -
Spine
NuVasive: Court Overturns $102 Million Award to Medtronic
By TESS STYNES NuVasive Inc. said a federal appeals court panel overturned a roughly $102 million jury award to medical device maker Medtronic PLC…
Read More » -
Financial
NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results
Company Provides 2015 Financial Performance Guidance Reflective of Updated Non-GAAP Definition SAN DIEGO, CA–(Marketwired – February 24, 2015) – Fourth…
Read More » -
Spine
Final Decision in NuVasive’s Inter Partes Review of Warsaw Orthopedic Patent
Ron Ro The Patent Trial and Appeals Board (the “Board”) recently issued Final Written Decisions disposing of two inter partes reviews that NuVasive filed…
Read More » -
Financial
NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link
SAN DIEGO, CA–(Marketwired – January 12, 2015) – Pat Miles Named President and Chief Operating Officer Matt Link Named President,…
Read More » -
Financial
NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance
NuVasive, Inc. (NASDAQ: NUVA) NuVasive, Inc. (NASDAQ: NUVA) (“NuVasive” or the “Company”), a medical device company focused on developing minimally…
Read More » -
Uncategorized
NuVasive Forever Barred From Using NEUROVISION Trademark
Los Angeles, September 5, 2014 – A Los Angeles federal judge issued a permanent injunction earlier this week against NuVasive,…
Read More » -
Spine
Judge denies NuVasive in NeuroVision spat, cancels trademark
August 11, 2014 by Brad Perriello A federal judge denies NuVasive’s bid to overturn a $30 million trademark infringement loss and cancels…
Read More »